|

Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities

RECRUITINGN/ASponsored by Montclair State University
Actively Recruiting
PhaseN/A
SponsorMontclair State University
Started2025-04-30
Est. completion2027-09
Eligibility
Age8 Years – 14 Years
Healthy vol.Accepted
Locations2 sites

Summary

The goal of this clinical trial is to investigate neural constructs related to anxiety symptoms in response to Facing Your Fears (FYF) treatment in autistic participants with co-occurring anxiety. Researchers will compare participants receiving immediate FYF intervention to those in the waitlist control group (receiving treatment as usual) to see if there are differences in neural constructs and anxiety symptom changes over the study period. Participants will: * Complete the Facing Your Fears (FYF) intervention if assigned to the immediate treatment group * Continue their usual treatment during a waitlist period if assigned to the control group, followed by the opportunity to participate in FYF intervention after the waiting period ends * Complete assessments of neural constructs, anxiety symptoms, and other measures

Eligibility

Age: 8 Years – 14 YearsHealthy volunteers accepted
Inclusion Criteria:

* Between the ages of 8 and 14
* Have significant deficits in reciprocal social behavior as defined by a score of 11 or above on the parent-report SCQ questionnaire
* Are verbally fluent in English, enabling them to participate in the appropriate modules (3 or 4) of the researcher-administered ADOS-2
* Have an estimated verbal IQ of 70 or above as determined by the researcher-administered KBIT-2
* Have clinically significant anxiety symptoms as defined by significant elevations on either the parent-report SCARED questionnaire or the parent-report PRAS-ASD questionnaire
* Have a legal guardian who can provide consent for their child's participation as well as their own participation in the intervention alongside their child. If the legal guardian is unable to participate in the intervention themselves but would like for their child to receive the intervention with another caregiver who lives with the child, the legal guardian will still be the one to sign the consent form, but will provide permission for another caregiver (logged on the consent form) to participate in the intervention alongside the child

Exclusion Criteria:

* Fail to meet any of the above inclusion criteria
* If it is determined by the research team via parent report or direct observation that the child has a severe medical or psychiatric impairment (e.g., psychosis, severe aggressive behavior, or other severe clinical symptoms) that require more intensive treatment such as day treatment or hospitalization

Conditions2

AnxietyAutism Spectrum Disorder

Locations2 sites

New Jersey

1 site
Montclair State University
Montclair, New Jersey, 07043
Erin Kang, PhD973-655-3615kange@montclair.edu

Pennsylvania

1 site
Drexel University
Philadelphia, Pennsylvania, 19104
Tamara Rosen, PhD215-571-3401ter32@drexel.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.